Holen Sie sich die Stockscreener-App
0.00
0.00%
0.00
Vitro Biopharma, Inc. Aktie (VTRO) Neueste Nachrichten
Biopharmaceutical Culture Media Market Insight 2025 is Exhibitin - WICZ
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
6 cultured meat companies making waves - Labiotech.eu
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire
Biopharmaceutical Culture Media Industry Trends & Drivers - Economica
Vitro Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2024 - Marketscreener.com
Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights
[Updated] Biopharmaceutical Culture Media Market Size Analysis - Economica
Vitro Diagnostics (OTCMKTS:VODG) & Cidara Therapeutics (NASDAQ:CDTX) Critical Comparison - Defense World
FDA’s lab-developed test rule could be first test of agency’s power post-Chevron - BioPharma Dive
Vitro Biopharma, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - Yahoo Finance
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - PR Newswire
FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit - Yahoo Finance
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights - PR Newswire
Best Biotech Stocks to Buy in 2025 - The Motley Fool
Fapon Empowers Indian IVD Manufacturers at Medical Fair India 2024 - PR Newswire
Morgan Stanley likes biopharma as a defensive play — giving one stock 119% upside - CNBC
Swiss investment firm denies acquisition bid for Boryung Biopharma - KBR
Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc. - PR Newswire
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments - StockTitan
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development - PR Newswire
IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha
Startup aims to make lab-grown human eggs, transforming options for creating families - NPR
VTRO IPO NewsStem cell biotech Vitro Biopharma sets terms for $10 million IPO - Renaissance Capital
CYPRE’S 3D in Vitro Platform Advances New Insights into the Tumor Microenvironment, Drives Data in 30 Days for Clients - Business Wire
Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire
This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF - STAT
Who are the leading innovators in in-vitro T-cell activation for the pharmaceutical industry? - Pharmaceutical Technology
In Vitro Glycoengineering – Suitability For BioPharma Manufacturing - BioProcess Online
SeQure Dx Emerges From Stealth Mode to Fulfill the Promise of On-Target Gene Editing Therapies for Biopharma Partners, Physicians, and Patients - Business Wire
Is Vitro Biopharma Inc. IPO a Good Buy? - Benzinga
Vitro Biopharma Names Chris Furman Chief Executive Officer - Yahoo Finance
Everlife-backed CPC Diagnostics buys i-chroma brand biz of South Korea-based company - VCCircle
The 10 most innovative biotech companies in 2022 - Fast Company
Business of Biotechniques 2022 - BioTechniques
Schrödinger picks up protein crystallographer XTAL BioStructures - Fierce Biotech
Adagio Therapeutics Inc. (NASDAQ: ADGI) Offers Update About In Vitro Analysis On ADG20's Neutralizing Activity Against Omicron - BP Journal
43 Top Biopharma Startups and Companies in Germany - EU-Startups
Emulate enhances tech aimed at supporting disease research and drug development - BioPharma-Reporter.com
Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine - StockTitan
This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines - Science
Cocrystal Pharma Inc (NASDAQ: COCP)'s SARS-CoV-2 3CL Protease Lead CDI-45205 Demonstrates Vitro Activity Against the SARS-CoV-2 Delta and Gamma Variants - BP Journal
Developing A Robust In Vitro Intestinal Model For Preclinical Candidate Screening Of GI Toxicity - Pharmaceutical Online
Aytu BioPharma Announces Publication of In Vitro Study Demonstrating That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells - AccessWire
Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter - AccessWire
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director - BioSpace
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech - PR Newswire
Auris Medical Holdings Ltd. (NASDAQ:EARS) Reports Positive AM-301 In Vitro Study Data Against SARS-CoV-2 - BP Journal
Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro - News-Medical.Net
Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites - BioSpace
Proteostasis Therapeutics Inc. (NASDAQ:PTI) Releases In Vitro PTI-129 Results As A possible COVID-19 Treatment Candidate - BP Journal
VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30 th 2019 financial results of operations. - SEC.gov
Study: Effects of in vitro fertilization depend on genetic variation inherited from parents - News-Medical.Net
Vitro Biopharma Files New Patents for Stem Cell Therapy of Neurological Conditions - AccessWire
Vitro Biopharma Launches New Products to Advance Breast Cancer Treatment - AccessWire
In Vitro Toxicology Testing Market Growth, Drivers, and Opportunities - MarketsandMarkets
Vitro Biopharma Launches New Bioanalytical Services and Novel Stem Cell-Derived Renal & Neural Cells - AccessWire
Vitro Biopharma Announces Advancement of its Traumatic Brain Injury Clinical Trial and a Favorable Ruling from the FDA - AccessWire
Vitro Biopharma Launches MSC-derived Cardiac and Neural Cells for Pre-clinical Toxicology Testing - AccessWire
Vitro Biopharma Announces Advances in Clinical Application of Stem Cell Therapy for Neurological Conditions - AccessWire
Alternatives to Stem Cell Transplants Supported by Key Medical Breakthroughs of 2014 - AccessWire
Vitro Biopharma Launches new Cell Lines to Bolster Revenue Growth - AccessWire
Vitro Biopharma Receives Frost & Sullivan Technology Innovation Leadership Award: 2014 Best Practices for Stem Cell Tools & Technology in North America - AccessWire
Vitro Biopharma Announces Advances in Stem Cell Therapy without Transplants - AccessWire
Vitro Biopharma Revenues Continue to Accelerate Towards Profitability - AccessWire
Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous Stem Cell Activation for Therapeutic Benefit - AccessWire
Neuromics and Vitro Biopharma Expand Collaboration to Target Drug Discovery and Regenerative Medicine Markets - AccessWire
Vitro Biopharma Launches New Website - Cision News
New Self Contained Stem Cell Workstation Makes Atmospheric Control Easier - BioProcess Online
0.08%
0.05%
Kapitalisierung:
|
Volumen (24h):